“…First, endogenous monoamine level was augmented by incubation in its immediate biochemical precursor (Sakharov, 1991;Diefenbach et al, 1995). Conversely, the action of 5-HT and DA was reduced by treating the embryos with commonly used aromatic amino acid decarboxylase inhibitor 3-hydroxybenzylhydrazine (Treseder et al, 2003), specific inhibitor of tryptophan 5-hydroxylase activity L-pchlorophenylalanine (Baker et al, 1993;Diefenbach et al, 1995;Pani and Croll, 1998), methylated analogues of respective monoamines (Sloley and Orikasa, 1988) and receptor antagonists (Goldberg et al, 1994;Pavlova, 2001). Developmental changes were correlated with changes in anti-5-HT immunofluorescence in Helisoma, and glyoxylate-induced fluorescence of dopamine in Lymnaea within the first anterior neurones.…”